The cross-regulation between the Type 1 interferon and NF-κB pathways was also found during viral infections [48] and later supported by in silico study that identified binding sites for both factors in the promoters of proinflammatory genes [49]. The gene discussed is NFKB1; the disease is viral infectious disease.